
Imitop 500 mg/500 mg Injection
Marketer
Sanat Products Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Imitop 500 mg/500 mg Injection
Combiflox 500 mg/500 mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare professional, this medication requires adherence to the prescribed schedule; complete the entire course regardless of symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions, such as redness, swelling, and soreness, may occur but typically subside. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., hives, itching, swelling, breathing difficulties). Inform your doctor of all current medications, and pregnant or breastfeeding individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, refrain from driving if drowsiness or dizziness occurs.
Primary Ingredients of Imitop 500 mg/500 mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Imitop 500 mg/500 mg Injection
Life-threatening bacterial infections
Major Benefits of Imitop 500 mg/500 mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Imitop 500 mg/500 mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imitop 500 mg/500 mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Imitop 500 mg/500 mg Injection works:
Imipenem/Cilastatin 500 mg/500 mg Injection (Imitop) combines an antibiotic, imipenem, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Cilastatin protects imipenem from enzymatic degradation (by dehydropeptidase I), thus prolonging its therapeutic effectiveness within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imitop 500 mg/500 mg Injection may pose unknown safety risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Imitop 500 mg/500 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The administration of Imitop 500 mg/500 mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingUNSAFE
Administering Imitop 500 mg/500 mg Injection may induce adverse reactions impacting driving capabilities. Certain side effects, including hallucinations (visual, auditory, or tactile), can impair some patients' ability to operate a vehicle.
KidneyCAUTION
The administration of Imitop 500 mg/500 mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Imitop 500 mg/500 mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Imitop 500 mg/500 mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Imitop 500 mg/500 mg Injection :
Should you inadvertently skip a dose of Imitop 500 mg/500 mg Injection, seek medical advice from your physician.
Facts to Know About Imitop 500 mg/500 mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
